The role of natriuretic peptide-guided therapy in heart failure management

被引：0
|
作者：
Kern, T. [1 ]
Kedan, I.
Kimchi, A. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
NEW INSIGHTS INTO MECHANISMS AND MANAGEMENT OF HEART DISEASE | 2013年
关键词：
Heart failure; natriuretic peptide; guided therapy; BNP; NT-proBNP; MORBIDITY; TRIAL; CARE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Natriuretic peptide has been validated as a useful biomarker in the diagnosis of heart failure. Its role in guiding medical management of heart failure is not well established. Our objective is to determine if natriuretic peptide-guided therapy is associated with improved outcomes for heart failure patients. We conducted a PubMed search to identify prospective randomized controlled trials evaluating natriuretic peptide-guided therapy. 12 trials (2,688 patients) comparing natriuretic peptide-guided therapy to standard therapy for heart failure patients were identified, with follow-up times ranging from 3 months to 3 years. Our data indicates that natriuretic peptide levels and all-cause mortality rates do not appear to benefit from natriuretic peptide-guided therapy compared to standard therapy. However, a decreased rate of cardiovascular events does appear to be associated with natriuretic peptide-guided therapy.
引用
收藏
页码：127 / 130
页数：4
相关论文
共 50 条
  • [41] Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials
    Savarese, G.
    Trimarco, B.
    Dellegrottaglie, S.
    Prastaro, M.
    Gambardella, F.
    Rengo, G.
    Leosco, D.
    Filardi, P. Perrone
    EUROPEAN HEART JOURNAL, 2013, 34 : 621 - 621
  • [42] The role of body mass index on a n-terminal pro brain natriuretic peptide-guided versus a symptom-guided management in heart failure patients with reduced ejection fraction
    Marcks, N. G. H. M. Nick
    Armas, K.
    Brunner-La Rocca, H. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 225 - 225
  • [43] Age Does Not Modify the Impact of Natriuretic Peptide-Guided Therapy on Clinical Outcomes or Serial Natriuretic Peptide Levels
    Hood, Caleb J.
    Gupta, Anand
    Hendren, Nicholas S.
    Farr, MaryJane A.
    Drazner, Mark H.
    Tang, Wai Hong W.
    Grodin, Justin L.
    CIRCULATION, 2022, 146
  • [44] Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches
    Stienen, Susan
    Bhatt, Ankeet
    Ferreira, Joao Pedro
    Vaduganathan, Muthiah
    Januzzi, James
    Adams, Kirkwood
    Tardif, Jean-Claude
    Rossignol, Patrick
    Zannad, Faiez
    HEART FAILURE REVIEWS, 2021, 26 (01) : 11 - 21
  • [45] N-Terminal Pro-B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure
    Lainchbury, John G.
    Troughton, Richard W.
    Strangman, Kim M.
    Frampton, Christopher M.
    Pilbrow, Anna
    Yandle, Timothy G.
    Hamid, Amjad K.
    Nicholls, M. Gary
    Richards, A. Mark
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 55 (01) : 53 - 60
  • [46] Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches
    Susan Stienen
    Ankeet Bhatt
    João Pedro Ferreira
    Muthiah Vaduganathan
    James Januzzi
    Kirkwood Adams
    Jean-Claude Tardif
    Patrick Rossignol
    Faiez Zannad
    Heart Failure Reviews, 2021, 26 : 11 - 21
  • [47] B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure: a systematic review with meta-analysis
    De Vecchis, Renato
    Esposito, Claudia
    Di Biase, Giuseppina
    Ariano, Carmelina
    Giasi, Anna
    Cioppa, Carmela
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2014, 15 (02) : 122 - 134
  • [48] Effect of Natriuretic Peptide-Guided Therapy on Outcomes in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
    Felker, G. Michael
    Anstrom, Kevin J.
    Adams, Kirkwood F.
    Ezekowitz, Justin A.
    Fiuzat, Mona
    Houston-Miller, Nancy
    Januzzi, James L., Jr.
    Mark, Daniel B.
    Pina, Ileana L.
    Passmore, Gayle
    Whellan, David J.
    Yang, Hongqiu
    Cooper, Lawton S.
    Leifer, Eric S.
    Desvigne-Nickens, Patrice
    O'Connor, Christopher M.
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (11) : 830 - 830
  • [49] Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure
    Pufulete M.
    Higgins J.P.T.
    Rogers C.A.
    Dreyer L.
    Hollingworth W.
    Dayer M.
    Nightingale A.
    McDonagh T.
    Reeves B.C.
    Systematic Reviews, 3 (1)
  • [50] B-type natriuretic peptide-guided therapy vs. conventional care in outpatients with chronic heart failure: a retrospective cohort study
    De Vecchis, R.
    Di Biase, G.
    Ariano, C.
    Fusco, A.
    Cioppa, C.
    Giasi, A.
    Cantatrione, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S96 - S97
12345